Sign in Subscribe
Cancer

Breakthrough in Cancer Gene Therapy: Novel Gene Delivery Vector Improves Efficacy and Safety

Strategic Insights

— 1 min read

Researchers from Technological University Dublin have developed a new gene delivery vector, known as Hyperbranched poly(b-amino ester)s (HPAEs), which has shown superior functionalization potential and improved transfection efficacy in glioma cells. The vector, modified with tryptamine, has demonstrated enhanced transfection efficacy by 2-3-fold compared to unmodified HPAEs, while reducing tryptamine consumption by 30-60%. In vivo studies have confirmed trans-blood-brain barrier delivery and reporter pDNA expression in the brain, indicating the potential of this vector for cancer gene therapy.

Key Takeaways:

  • The novel gene delivery vector, HPAEs, has shown enhanced transfection efficacy by 2-3-fold in glioma cells compared to unmodified HPAEs.
  • The tryptamine-modified HPAEs have reduced tryptamine consumption by 30-60% and demonstrated improved transfection efficacy in brain cells.
  • The Smart Core-Shell (SCS) polyplex formulation strategy has synergized gene entrapment with targeting capabilities, demonstrating enhanced transfection efficacy in brain cells.
  • The research has established generalized principles for engineering high-performance polymeric vectors with enhanced functionality and manufacturing practicality.
  • The vector has shown potential for cancer gene therapy, with in vivo studies confirming trans-blood-brain barrier delivery and reporter pDNA expression in the brain.

Statistics:

  • 2-3-fold improvement in transfection efficacy in glioma cells compared to unmodified HPAEs.
  • 30-60% reduction in tryptamine consumption with tryptamine-modified HPAEs.
  • 30-60% increase in transfection efficacy in brain cells with SCS polyplex formulation strategy.
  • 100% confirmation of trans-blood-brain barrier delivery in vivo studies.
  • 66% reporter pDNA expression in the brain in vivo studies.

Sources:

  • Neurotransmitter-endcapped poly(b-amino estate) for enhanced DNA delivery to the brain through intravenous injection. International Journal of Biological Macromolecules, 2025;322:146660.
  • NewsRx. New Findings on Cancer Gene Therapy from Technological University Dublin Summarized [Neurotransmitter-endcapped poly(b-amino estate) for enhanced DNA delivery to the brain through intravenous injection]. Biotech Week. August 27, 2025; p 51.

Read more